Massachusetts Financial Services
TNGX icon

Massachusetts Financial Services’s Tango Therapeutics TNGX Stock Holding History

Massachusetts Financial Services’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Sell
11,139
-16,159
-59% -$399K ﹤0.01% 973
2026
Q1 		$571K Sell
27,298
-725
-3% -$10.1K ﹤0.01% 887
2025
Q4 		$248K Buy
+28,023
New +$241K ﹤0.01% 907
2024
Q1 		– Sell
-23,980
Closed -$237K – 883
2023
Q4 		$237K Buy
+23,980
New +$208K ﹤0.01% 828

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Massachusetts Financial Services's TNGX Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Tango Therapeutics (TNGX) stake by 59% in Q2 2026, selling an estimated $399K and leaving 11,139 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Massachusetts Financial Services first reported a position in TNGX in Q4 2023 and has held it in 4 quarters since. The position peaked at $571K in Q1 2026. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Massachusetts Financial Services held 11,139 shares of Tango Therapeutics worth $348K as of Q2 2026.
  • Massachusetts Financial Services sold 16,159 Tango Therapeutics shares in Q2 2026, an estimated $399K.
  • Tango Therapeutics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #973 holding.
  • Massachusetts Financial Services first reported a position in Tango Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Massachusetts Financial Services's Tango Therapeutics position peaked at $571K in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.